Meta-analysis of the prevalence of depression among breast cancer survivors in Iran: an urgent need for community supportive care programs
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
OBJECTIVES: Depression, which is the most common comorbidity in breast cancer (BC) patients, has adverse effects on patients’ quality of life, disease progress, and survival. METHODS: The protocol of this study was registered in PROSPERO (registration No. CRD42019121494). We electronically searched published studies through January 2019 with the aim of finding articles that investigated the prevalence of depression among BC survivors. Web of Science, Scopus, PubMed/MEDLINE, Science Direct, and Google Scholar were searched to obtain relevant published studies. This review included 14 cross-sectional and 4 cohort studies published from 2000 to 2018. We used a random-effects model to conduct the meta-analysis and generated a summary estimate for the pooled prevalence with 95% confidence intervals (CIs). A subgroup analysis was also conducted based on the depression assessment tool used and the study design. RESULTS: The total sample size of the studies contained 2,799 women with BC, including 1,228 women who were diagnosed with depression. The pooled prevalence of depression among Iranian women with BC was 46.83% (95% CI, 33.77 to 59.88) with significant heterogeneity (I2=98.5%; p<0.001). The prevalence of depression ranged from 14.00% (95% CI, 4.91 to 23.09) to 95.90% (95% CI, 91.97 to 99.83). The results of the subgroup analyses suggested that the depression assessment tool, year of publication, and study design were sources of heterogeneity. CONCLUSIONS: Our findings indicate a high prevalence of depression among BC patients, underscoring the urgent need for clinicians and health authorities to provide well-defined social and psychological supportive care programs for these patients.
Abstract
OBJECTIVES: Depression, which is the most common comorbidity in breast cancer (BC) patients, has adverse effects on patients’ quality of life, disease progress, and survival. METHODS: The protocol of this study was registered in PROSPERO (registration No. CRD42019121494). We electronically searched published studies through January 2019 with the aim of finding articles that investigated the prevalence of depression among BC survivors. Web of Science, Scopus, PubMed/MEDLINE, Science Direct, and Google Scholar were searched to obtain relevant published studies. This review included 14 cross-sectional and 4 cohort studies published from 2000 to 2018. We used a random-effects model to conduct the meta-analysis and generated a summary estimate for the pooled prevalence with 95% confidence intervals (CIs). A subgroup analysis was also conducted based on the depression assessment tool used and the study design. RESULTS: The total sample size of the studies contained 2,799 women with BC, including 1,228 women who were diagnosed with depression. The pooled prevalence of depression among Iranian women with BC was 46.83% (95% CI, 33.77 to 59.88) with significant heterogeneity (I2=98.5%; p<0.001). The prevalence of depression ranged from 14.00% (95% CI, 4.91 to 23.09) to 95.90% (95% CI, 91.97 to 99.83). The results of the subgroup analyses suggested that the depression assessment tool, year of publication, and study design were sources of heterogeneity. CONCLUSIONS: Our findings indicate a high prevalence of depression among BC patients, underscoring the urgent need for clinicians and health authorities to provide well-defined social and psychological supportive care programs for these patients.
참고문헌 (62)
- Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 68, pp.394~424 (2018)
- Saeedi-Saedi H, "Evaluation of emotional distress in breast cancer patients", Iran J Cancer Prev, 8, pp.36~41 (2015)
- Dianatinasab M, "Socioeconomic factors, health behavior, and late-stage diagnosis of breast cancer : considering the impact of delay in diagnosis", Clin Breast Cancer, 18, pp.239~245 (2018)
- Tabrizi FM, "Health promoting behavior and influencing factors in Iranian breast cancer survivors", Asian Pac J Cancer Prev, 16, pp.1729~1736 (2015)
- Cvetković J, "Depression in breast cancer patients", Psychiatry Res, 240, pp.343~347 (2016)
- Burgess C, "Depression and anxiety in women with early breast cancer : five year observational cohort study", BMJ, 330, pp.702~ (2005)
- Ho SS, "Anxiety, depression and quality of life in Chinese women with breast cancer during and after treatment : a comparative evaluation", Eur J Oncol Nurs, 17, pp.877~882 (2013)
- DeSantis CE, "Breast cancer statistics, 2017, racial disparity in mortality by state", CA Cancer J Clin, 67, pp.439~448 (2017)
- Fann JR, "Major depression after breast cancer : a review of epidemiology and treatment", Gen Hosp Psychiatry, 30, pp.112~126 (2008)
- Walker J, "Prevalence, associations, and adequacy of treatment of major depression in patients with cancer : a cross-sectional analysis of routinely collected clinical data", Lancet Psychiatry, 1, pp.343~350 (2014)
- Brandão T, "Psychological adjustment after breast cancer : a systematic review of longitudinal studies", Psychooncology, 26, pp.917~926 (2017)
- Kashani F, "The effects of relaxation on reducing depression, anxiety and stress in women who underwent mastectomy for breast cancer", Iran J Nurs Midwifery Res, 17, pp.30~33 (2012)
- Baniasadi H, "Effectiveness of mindfulness training on reduction of distress of patients infected by breast cancer", Procedia Soc Behav Sci, 114, pp.944~948 (2014)
- Hu Y, "Association between dyadic interventions and outcomes in cancer patients : a meta-analysis", Support Care Cancer, 27, pp.745~761 (2019)
- McInnes MD, "Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies : the PRISMA-DTA statement", JAMA, 319, pp.388~396 (2018)
- Loney PL, "Critical appraisal of the health research literature : prevalence or incidence of a health problem", Chronic Dis Can, 19, pp.170~176 (1998)
- Higgins JP, "Measuring inconsistency in meta-analyses", BMJ, 327, pp.557~560 (2003)
- Egger M, "Bias in meta-analysis detected by a simple, graphical test", BMJ, 315, pp.629~634 (1997)
- Sterne JA, "Funnel plots for detecting bias in meta-analysis : guidelines on choice of axis", J Clin Epidemiol, 54, pp.1046~1055 (2001)
- "METAN: Stata module for fixed and random effects meta-analysis" (2007)[URL]
- Ardebil MD, "Depression and health related quality of life in breast cancer patients", Acad J Cancer Res, 4, pp.43~46 (2011)
- Haghighat S, "Factors predicting fatigue in breast cancer patients", Support Care Cancer, 11, pp.533~538 (2003)
- Heydarheydari S, "The relationship between anxiety and depression with breast cancer screening in women referring to the mammography clinics in Kermanshah, 2013-2014", J Clin Res Paramed Sci, 4, pp.231~237 (2015)
- Mashhadi MA, "Evaluation of depression in patients with cancer in South of Iran(Zahedan)", Iran J Cancer Prev, 6, pp.12~16 (2013)
- Derakhshanfar A, "Frequency of depression in breast cancer patients : a study in Farshchian and Besat Hospitals of Hamedan during 2007-8", Iran J Surg, 21, pp.68~74 (2013)
- Montazeri A, "Depression and the use of complementary medicine among breast cancer patients", Support Care Cancer, 13, pp.339~342 (2005)
- Musarezaie A, "Survey the anxiety and depression among breast cancer patients referred to the specialized Isfahan hospital of cancer", Iran J Health Syst Res, 10, pp.39~48 (2014)
- Nikbakhsh N, "Prevalence of depression and anxiety among cancer patients", Caspian J Intern Med, 5, pp.167~170 (2014)
- Ramezani T, "Degree of depression and the need for counseling among women with breast cancer in Kerman chemotherapeutic centers", Iran J Psychiatry Clin Psychol, 6, pp.70~80 (2001)
- Shakeri J, "Studying the amount of depression and its role in predicting the quality of life of women with breast cancer", Asian Pac J Cancer Prev, 17, pp.643~646 (2016)
- Taghavi M, "Investigating the relation of depression and religious coping and social support in women with breast cancer", J Isfahan Med Sch, 28, pp.901~908 (2011)
- Mehrabani F, "Unpleasant emotions(stress, anxiety and depression)and it is relationship with parental bonding and disease and demographic characteristics in patients with breast cancer", Iran Q J Breast Dis, 9, pp.42~52 (2016)
- Montazeri A, "Anxiety and depression in Iranian breast cancer patients before and after diagnosis", Eur J Cancer Care(Engl), 9, pp.151~157 (2000)
- Montazeri A, "Anxiety and depression in breast cancer patients before and after participation in a cancer support group", Patient Educ Couns, 45, pp.195~198 (2001)
- Montazeri A, "The role of depression in the development of breast cancer : analysis of registry data from a single institute", Asian Pac J Cancer Prev, 5, pp.316~319 (2004)
- Vahdaninia M, "What do predict anxiety and depression in breast cancer patients? A follow-up study", Soc Psychiatry Psychiatr Epidemiol, 45, pp.355~361 (2010)
- Veisani Y, "Trends of postpartum depression in Iran : a systematic review and meta-analysis", Depress Res Treat, 2013, pp.291029~ (2013)
- Masoumi SZ, "Prevalence of depression among infertile couples in Iran : a meta-analysis study", Iran J Public Health, 42, pp.458~466 (2013)
- Veisani Y, "Trends of postpartum depression in Iran : a systematic review and meta-analysis", Depress Res Treat, 2013, pp.291029~ (2013)
- Zainal NZ, "Prevalence of depression in breast cancer survivors : a systematic review of observational studies", Asian Pac J Cancer Prev, 14, pp.2649~2656 (2013)
- Bener A, "Depression, hopelessness and social support among breast cancer patients : in highly endogamous population", Asian Pac J Cancer Prev, 18, pp.1889~1896 (2017)
- Maass SW, "The prevalence of long-term symptoms of depression and anxiety after breast cancer treatment : a systematic review", Maturitas, 82, pp.100~108 (2015)
- Chen X, "Prevalence of depression and its related factors among Chinese women with breast cancer", Acta Oncol, 48, pp.1128~1136 (2009)
- Eversley R, "Post-treatment symptoms among ethnic minority breast cancer survivors", Oncol Nurs Forum, 32, pp.250~256 (2005)
- Morrill EF, "The interaction of post-traumatic growth and post-traumatic stress symptoms in predicting depressive symptoms and quality of life", Psychooncology, 17, pp.948~953 (2008)
- Den Oudsten BL, "Predictors of depressive symptoms 12 months after surgical treatment of early-stage breast cancer", Psychooncology, 18, pp.1230~1237 (2009)
- Broeckel JA, "Quality of life after adjuvant chemotherapy for breast cancer", Breast Cancer Res Treat, 62, pp.141~150 (2000)
- Pumo V, "Psychological and sexual disorders in long-term breast cancer survivors", Cancer Manag Res, 4, pp.61~65 (2012)
- Fouladi N, "Sexual life after mastectomy in breast cancer survivors : a qualitative study", Psychooncology, 27, pp.434~441 (2018)
- Pinto AC., "Sexuality and breast cancer: prime time for young patients", J Thorac Dis, 5(Suppl 1), pp.S81~S86 (2013)
- Harirchi I, "Sexual function in breast cancer patients : a prospective study from Iran", J Exp Clin Cancer Res, 31, pp.20~ (2012)
- Chen CL, "Body image and its predictors in breast cancer patients receiving surgery", Cancer Nurs, 35, pp.E10~E16 (2012)
- Montazeri A, "Delayed presentation in breast cancer : a study in Iranian women", BMC Womens Health, 3, pp.4~ (2003)
- Fisher C, ""Motherhood"in the context of living with breast cancer", Cancer Nurs, 35, pp.157~163 (2012)
- Warmenhoven F, "The Beck Depression Inventory(BDI-II)and a single screening question as screening tools for depressive disorder in Dutch advanced cancer patients", Support Care Cancer, 20, pp.319~324 (2012)
- Wang GL, "The HADS and the DT for screening psychosocial distress of cancer patients in Taiwan", Psychooncology, 20, pp.639~646 (2011)
- Cusin C, "Handbook of clinical rating scales and assessment in psychiatry and mental health", pp.7~35 (2010), Humana Press
- Hann D, "Measurement of depressive symptoms in cancer patients : evaluation of the Center for Epidemiological Studies Depression Scale(CES-D)", J Psychosom Res, 46, pp.437~443 (1999)
- Osborne RH, "The value of the Hospital Anxiety and Depression Scale(HADS)for comparing women with early onset breast cancer with population-based reference women", Qual Life Res, 13, pp.191~206 (2004)
- Noorbala AA, "Evaluation of mental disorders incidence trend in Iran", Daneshvar Med, 21, pp.1~10 (2014)
- Vin-Raviv N, "Depression and anxiety disorders among hospitalized women with breast cancer", PLoS One, 10, pp.e0129169~ (2015)
- Mehnert A, "Psychological comorbidity and health-related quality of life and its association with awareness, utilization, and need for psychosocial support in a cancer register-based sample of long-term breast cancer survivors", J Psychosom Res, 64, pp.383~391 (2008)